JPRN-UMIN000030977已完成未知
Prospective evaluation of minimal residual disease in acute myeloid leukemia using TIM-3 as a leukemia marker - MRD study for acute myeloid leukemia using TIM-3 as a leukemic stem cell specific surface marker
Department of Medicine and Biosystemic Sciences, Kyushu University Graduate School of Medicine0 个研究点目标入组 50 人开始时间: 2018年1月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Refractory or relapsed acute myeloid leukemia patients (2)Secondary AML patients (3)Acute promyelocytic leukemia patients (4) A patient whom the researchers decide as an inappropriate case
研究者
相似试验
已完成
不适用
Prognostic value of minimal residual disease detection by multiparameter flow cytometry (EuroFlow method) in patients with multiple myeloma who underwent autologous stem cell transplantation: comparison with sequencing-based methodmultiple myelomaJPRN-UMIN000022238Kanazawa University66
已完成
Unknown
Survey on Minimal Residual Disease (MRD) Measurement in Multiple MyelomaMultiple MyelomaJPRN-UMIN000052475Sanofi K.K.158
已完成
不适用
Prognostic Role of Minimal Residual Disease in Acute Myeloid LeukemiaWilms TumorAcute Myeloid LeukemiaMinimal Residual DiseaseNCT02714790A.O.U. Città della Salute e della Scienza281
招募中
不适用
Prospective evaluation of disease free survival and Quality of Life following microvascular reconstruction in early oral squamous cell carcinomaC06.9Mouth, unspecifiedDRKS00013041Klinik und Poliklinik für Mund-, Kiefer- und GesichtschirurgieKopfklinikUniversitätsklinikum Heidelberg50
招募中
不适用
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLCNon-small Cell Lung CancerNCT06198868Jiangsu Cancer Institute & Hospital60